Jonathan Hurov

2.0k total citations
17 papers, 1.3k citations indexed

About

Jonathan Hurov is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jonathan Hurov has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Jonathan Hurov's work include Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (3 papers) and FOXO transcription factor regulation (3 papers). Jonathan Hurov is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), RNA modifications and cancer (3 papers) and FOXO transcription factor regulation (3 papers). Jonathan Hurov collaborates with scholars based in United States, Ireland and China. Jonathan Hurov's co-authors include Helen Piwnica‐Worms, Lynn S. White, Terry Woodford‐Thomas, Lewis C. Cantley, Byron DeLaBarre, Ekaterina Bobrovnikova-Marjon, Abhishek Jha, Stefan Größ, Thomas Graf and Manav Korpal and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Jonathan Hurov

17 papers receiving 1.2k citations

Peers

Jonathan Hurov

ONCOL

HEMAT

Naoyuki Nishiya Japan

Heidi Sankala United States

Daniel T. Dransfield United States

Roberta Fiume Italy

Muling Mao United States

Daniela Barilá Italy

Nicole R. Murray United States

Laurie J. Reichling United States

Kian Leong Lee Singapore

Valerie L. Goss United States

Naoyuki Nishiya Japan

Jonathan Hurov

1.1k ×1.3

539 ×1.6

129 ×0.5

196 ×1.2

ONCOL

34 ×0.3

HEMAT

Citations per year, relative to Jonathan Hurov Jonathan Hurov (= 1×) peers Naoyuki Nishiya

Countries citing papers authored by Jonathan Hurov

Since Specialization

Citations

This map shows the geographic impact of Jonathan Hurov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Hurov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Hurov more than expected).

Fields of papers citing papers by Jonathan Hurov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Hurov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Hurov. The network helps show where Jonathan Hurov may publish in the future.

Co-authorship network of co-authors of Jonathan Hurov

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Hurov. A scholar is included among the top collaborators of Jonathan Hurov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Hurov. Jonathan Hurov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zhu, Eric, Daniël Blom, Shalini Sethumadhavan, et al.. (2020). 683 A novel mechanism of neuropilin-1 inhibition results in improved tumor growth inhibition in vivo. SHILAP Revista de lepidopterología. A410.1–A410. 1 indexed citations

Mellinghoff, Ingo K., Mehdi Touat, Elizabeth A. Maher, et al.. (2016). ACTR-46. AG120, A FIRST-IN-CLASS MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: RESULTS FROM THE PHASE 1 GLIOMA EXPANSION COHORTS. Neuro-Oncology. 18(suppl_6). vi12–vi12. 15 indexed citations

Ulanet, Danielle, Abhishek Jha, Sung Choe, et al.. (2014). Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition. PLoS ONE. 9(12). e115144–e115144. 39 indexed citations

DeLaBarre, Byron, Jonathan Hurov, Giovanni Cianchetta, Stuart Murray, & Lenny Dang. (2014). Action at a Distance: Allostery and the Development of Drugs to Target Cancer Cell Metabolism. Chemistry & Biology. 21(9). 1143–1161. 34 indexed citations

Bobrovnikova-Marjon, Ekaterina & Jonathan Hurov. (2014). Targeting Metabolic Changes in Cancer: Novel Therapeutic Approaches. Annual Review of Medicine. 65(1). 157–170. 44 indexed citations

Ulanet, Danielle, Abhishek Jha, Sung Choe, et al.. (2014). Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibition. Cancer & Metabolism. 2(S1). 21 indexed citations

Emerling, Brooke M., Jonathan Hurov, George Poulogiannis, et al.. (2013). Depletion of a Putatively Druggable Class of Phosphatidylinositol Kinases Inhibits Growth of p53-Null Tumors. Cell. 155(4). 844–857. 144 indexed citations

DeLaBarre, Byron, Stefan Größ, Cheng Fang, et al.. (2011). Full-Length Human Glutaminase in Complex with an Allosteric Inhibitor. Biochemistry. 50(50). 10764–10770. 123 indexed citations

Shan, Dandan, Jian‐Liang Li, Leeying Wu, et al.. (2010). GPAT3 and GPAT4 are regulated by insulin-stimulated phosphorylation and play distinct roles in adipogenesis. Journal of Lipid Research. 51(7). 1971–1981. 90 indexed citations

10.

Lennerz, Jochen K., Jonathan Hurov, Lynn S. White, et al.. (2010). Loss of Par-1a/MARK3/C-TAK1 Kinase Leads to Reduced Adiposity, Resistance to Hepatic Steatosis, and Defective Gluconeogenesis. Molecular and Cellular Biology. 30(21). 5043–5056. 39 indexed citations

11.

Hurov, Jonathan & Helen Piwnica‐Worms. (2007). The Par-1/MARK Family of Protein Kinases: From Polarity to Metabolism. Cell Cycle. 6(16). 1966–1969. 57 indexed citations

12.

Hurov, Jonathan, Mei Huang, Lynn S. White, et al.. (2007). Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo. Proceedings of the National Academy of Sciences. 104(13). 5680–5685. 61 indexed citations

13.

Schulze, Harald, Manav Korpal, Jonathan Hurov, et al.. (2006). Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood. 107(10). 3868–3875. 139 indexed citations

14.

Hurov, Jonathan, et al.. (2004). Atypical PKC Phosphorylates PAR-1 Kinases to Regulate Localization and Activity. Current Biology. 14(8). 736–741. 222 indexed citations

15.

Hurov, Jonathan, Thaddeus S. Stappenbeck, Christian M. Zmasek, et al.. (2001). Immune System Dysfunction and Autoimmune Disease in Mice Lacking Emk (Par-1) Protein Kinase. Molecular and Cellular Biology. 21(9). 3206–3219. 74 indexed citations

16.

Hurov, Jonathan, et al.. (2001). Absence of Apparent Phenotype in Mice Lacking Cdc25C Protein Phosphatase. Molecular and Cellular Biology. 21(12). 3853–3861. 149 indexed citations

17.

Hurov, Jonathan, et al.. (1992). Metabolic transitions in rat jaw muscles during postnatal development.. PubMed. 12(2). 98–106. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact